Literature DB >> 1508299

Reduced temporal lobe blood flow in Alzheimer's disease.

J L Eberling1, W J Jagust, B R Reed, M G Baker.   

Abstract

We used single photon emission computed tomography with the blood flow tracer [123I]N-isopropyl-p-iodoamphetamine (IMP) to study regional cerebral blood flow (rCBF) in 50 mildly and moderately demented Alzheimer's disease (AD) patients to evaluate rCBF as a function of disease severity. Relative rCBF (normalized to occipital cortex) was significantly lower than controls in temporal cortex for both mildly and moderately demented patients. Similar numbers of patients in both groups demonstrated perfusion abnormalities in temporal neocortex. Parietal cortex was more variably involved with greater numbers of moderately than mildly demented patients showing perfusion abnormalities. Relative rCBF in dirsolateral frontal cortex was reduced only in the moderately demented patients. Disease severity, as measured by the Mini Mental Status Examination, was associated with relative rCBF only in dorsolateral frontal and parietal cortex. These results suggest that the temporal lobes are the first neocortical regions affected by AD and that other cortical areas become involved as the disease progresses.

Entities:  

Mesh:

Year:  1992        PMID: 1508299     DOI: 10.1016/0197-4580(92)90076-a

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  15 in total

1.  Selective excitation of subtypes of neocortical interneurons by nicotinic receptors.

Authors:  J T Porter; B Cauli; K Tsuzuki; B Lambolez; J Rossier; E Audinat
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

Review 2.  Molecular neuroimaging in Alzheimer's disease.

Authors:  William Jagust
Journal:  NeuroRx       Date:  2004-04

Review 3.  What have we learned about the kallikrein-kinin and renin-angiotensin systems in neurological disorders?

Authors:  Maria da Graça Naffah-Mazzacoratti; Telma Luciana Furtado Gouveia; Priscila Santos Rodrigues Simões; Sandra Regina Perosa
Journal:  World J Biol Chem       Date:  2014-05-26

4.  Initial mini-mental state and cerebral perfusion in Alzheimer's disease.

Authors:  T Ones; I Midi; F Dede; N Tuncer; T Y Erdil; O Onultan; S Ceylan; S Inanir; H T Turoglu
Journal:  Clin Neuroradiol       Date:  2012-01-03       Impact factor: 3.649

5.  Constraints on the cerebral basis for semantic processing from neuroimaging studies of Alzheimer's disease.

Authors:  M Grossman; F Payer; K Onishi; T White-Devine; D Morrison; M D'Esposito; K Robinson; A Alavi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-08       Impact factor: 10.154

6.  Neuropsychology of memory and SPECT in the diagnosis and staging of dementia of Alzheimer type.

Authors:  J D Greene; K Miles; J R Hodges
Journal:  J Neurol       Date:  1996-02       Impact factor: 4.849

7.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

8.  Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism.

Authors:  M Lehtovirta; J Kuikka; S Helisalmi; P Hartikainen; A Mannermaa; M Ryynänen; H Soininen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-06       Impact factor: 10.154

9.  Assessment of cerebral perfusion with single-photon emission tomography in normal subjects and in patients with Alzheimer's disease: effects of region of interest selection.

Authors:  J J Claus; F van Harskamp; M M Breteler; E P Krenning; T J van der Cammen; A Hofman; D Hasan
Journal:  Eur J Nucl Med       Date:  1994-10

Review 10.  Biomarkers for evaluation of clinical efficacy of multipotential neuroprotective drugs for Alzheimer's and Parkinson's diseases.

Authors:  Ilan Halperin; Micaela Morelli; Amos D Korczyn; Moussa B H Youdim; Silvia A Mandel
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.